2021
DOI: 10.1002/jcla.23940
|View full text |Cite
|
Sign up to set email alerts
|

The biotin interference within interference suppressed immunoassays

Abstract: Background Reports of false laboratory findings due to a biotin supplementation have raised concerns about the safety of immunoassays. According to current research, biotin is known to cause interference in immunoassays. Since up to 70% of medical decisions are based on laboratory results and the significantly increased intake of biotin supplements in the recent years, the reliability of immunoassays is essential. Methods To evaluate this reliability two experiments were conducted. In the first experiment 59 i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 18 publications
0
12
0
Order By: Relevance
“…No clinical trials were found. Doses and duration varied by case report Some degree of improvement in hair growth or nail growth after 10 days to 6 months of treatment - Evidence only in populations with pathology for either poor hair or nail growth (e.g., uncombable hair syndrome, valproic acid-induced alopecia) - Can interfere with laboratory immunoassays (e.g., concentration of immunosuppressive drugs, thyroid function tests, cardiac enzymes, hepatitis, vitamin d) [ 30 33 ] - AAD** recommended discontinuation of biotin for promotion of hair regrowth ( https://dignicap.com/patient-instructions/ ) [ 34 ] * DHT dihydrotestosterone ** AAD American Academy of Dermatology …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…No clinical trials were found. Doses and duration varied by case report Some degree of improvement in hair growth or nail growth after 10 days to 6 months of treatment - Evidence only in populations with pathology for either poor hair or nail growth (e.g., uncombable hair syndrome, valproic acid-induced alopecia) - Can interfere with laboratory immunoassays (e.g., concentration of immunosuppressive drugs, thyroid function tests, cardiac enzymes, hepatitis, vitamin d) [ 30 33 ] - AAD** recommended discontinuation of biotin for promotion of hair regrowth ( https://dignicap.com/patient-instructions/ ) [ 34 ] * DHT dihydrotestosterone ** AAD American Academy of Dermatology …”
Section: Discussionmentioning
confidence: 99%
“…- Can interfere with laboratory immunoassays (e.g., concentration of immunosuppressive drugs, thyroid function tests, cardiac enzymes, hepatitis, vitamin d) [ 30 33 ]…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, changes in the measured values of sandwich immunoassays can lead to false low or high values in the measured results, depending on the concentrations and the relationships among the proteins, biotin, and reagents in the assays using biotin-avidin/streptavidin. Kabiri et al [22] studied biotin interference in protein measurements and concluded that biotin in the sample leads to false high values in sandwich immunoassays. Liu et al [23] observed that biotin in the sample led to a false negative result because the assay failed to detect the target Ab even though it was present in the sample.…”
Section: Discussionmentioning
confidence: 99%
“…Approximately 85% of chemiluminescence immunoassays are based on biotin-avidin/streptavidin and are used by more than twothirds of laboratories in China [20,21]. All laboratories using signal amplification through biotin-streptavidin interactions face the threat of misdiagnosis due to biotin interference caused by excessive biotin consumption [22,23].…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, it could represent a growing concern of an emerging interference in clinical immunoassays . Biotinylation might reduce the sensibility of an ELISA assay by preventing protein binding, interfering in the laboratory immunoassay results. , In most cases, researchers focus on the overall aspect of enzymatic biotin-labeling, and the remaining biomolecular behavior is not always mentioned. It is possible that just a few studies investigated, at the level of individual residues, the underlying basis of the changes induced by biotinylation with respect to the biotin-labeled experiments.…”
Section: Introductionmentioning
confidence: 99%